Citation: Tm. Sanger et al., Long-term olanzapine therapy in the treatment of bipolar I disorder: An open-label continuation phase study, J CLIN PSY, 62(4), 2001, pp. 273-281
Authors:
Dossenbach, MRK
Kratky, P
Schneidman, M
Grundy, SL
Metcalfe, S
Tollefson, GD
Belmaker, RH
Citation: Mrk. Dossenbach et al., Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone, J CLIN PSY, 62, 2001, pp. 28-34
Authors:
Dossenbach, MRK
Beuzen, JN
Avnon, M
Belmaker, RH
Elizur, A
Mark, M
Munitz, H
Schneidman, M
Shoshani, D
Kratky, P
Grundy, SL
Tollefson, GD
Citation: Mrk. Dossenbach et al., The effectiveness of olanzapine in treatment-refractory schizophrenia whenpatients are nonresponsive to or unable to tolerate clozapine, CLIN THER, 22(9), 2000, pp. 1021-1034
Authors:
Tohen, M
Jacobs, TG
Grundy, SL
McElroy, SL
Banov, MC
Janicak, PG
Sanger, T
Risser, R
Zhang, F
Toma, V
Francis, J
Tollefson, GD
Breier, A
Citation: M. Tohen et al., Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study, ARCH G PSYC, 57(9), 2000, pp. 841-849
Citation: Da. Bright et al., Differentiation of polychlorinated dibenzo-p-dioxin and dibenzofuran sources in coastal British Columbia, Canada, ENV TOX CH, 18(6), 1999, pp. 1097-1108
Authors:
Tohen, M
Sanger, TM
McElroy, SL
Tollefson, GD
Chengappa, R
Daniel, DG
Petty, F
Centorrino, F
Wang, R
Grundy, SL
Greaney, MG
Jacobs, TG
David, SR
Toma, V
Citation: M. Tohen et al., Olanzapine versus placebo in the treatment of acute mania, AM J PSYCHI, 156(5), 1999, pp. 702-709